A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
Hui Jing, Hening Lin(Howard Hughes Medical Institute), Jack Stupinski(Cornell University), Yashira L. Negrón Abril(Agios Pharmaceuticals (United States)), Keren Weiser(Cornell University), Bin He(Guiyang Medical University), Marisa Carbonaro(Regeneron (United States)), Paraskevi Giannakakou(Cornell University), Teresa Southard(Cornell University), Jing Hu(University of Michigan), Robert S. Weiss(Cornell University), Ying‐Ling Chiang(Cornell University)
Cited by 23
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function
|Proceedings of the National Academy of Sciences|2016|371
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
|Journal of Clinical Oncology|2019|364
The pathogen-associated <i>iroA</i> gene cluster mediates bacterial evasion of lipocalin 2
|Proceedings of the National Academy of Sciences|2006|312